Terms in this set (187)
A client is prescribed A
Ibandronate (Boniva) for
the treatment of
osteoporosis. Which is the
appropriate administration
route for this medication?
a. by mouth once a month
b. intramuscular every other
month
c. intradermal patch
changed once a week
d. tropically applied to
upper inner arm daily
______ inhibit osteoclast- bisphosphates
mediated bone resorption
and slow the cycle of bone
remodeling. Although a
modest increase in BMD is
typical, bone remodeling
may be suppressed to the
extent that normal bone
formation is impaired and
fracture risk increases.
______ are drugs are widely bisphosphates
used in the prevention and
treatment of osteoporosis.
,Common side effects of bisphosphates
______ include:
- anorexia
- weight loss
- gastritis
Teach the patient to take
the medication correctly to
improve its absorption and
decrease GI side effects.
______ include: bisphosphates
- Alendronate
- Ibandronate
- Risedronate
- Zoledronic acid
Renal function tests and bisphosphates
serum calcium must be
assessed before
administration of ______.
______ is available as a daily or Alendronate
weekly oral tablet.
______ is available as a once- Ibandronate
per-month oral tablet or
can be given every 3
months by IV infusion.
______ is given daily, weekly, Risedronate
or monthly based on the
dose.
,______ is secreted by the calcitonin
thyroid gland and inhibits
osteoclastic bone
resorption by directly
interacting with active
osteoclasts. Salmon
calcitonin is available in
intranasal form.
When ______ is used, calcium calcitonin
supplementation is
necessary to prevent
secondary
hyperparathyroidism.
______ ______ ______ ______ are selective estrogen receptor modulators
drugs used to treat
osteoporosis and mimic the
effect of estrogen on bone
by reducing bone
resorption without
stimulating the tissues of the
breast or uterus.
______ is a selective estrogen raloxifene
receptor modulator that
may decrease breast
cancer risk.
______ is a selective estrogen tamoxifen
receptor modulator that
blocks the estrogen
receptor sites of cancer
cells.
, ______ is a portion of human teriparatide
parathyroid hormone that is
used for the treatment of
osteoporosis by increasing
the action of osteoblasts
______ is the first drug for teriparatide
osteoporosis that stimulates
new bone formation rather
than just preventing further
bone loss.
______ may be used for denosumab
postmenopausal women
with osteoporosis who are
at high risk for fractures. It is
a monoclonal antibody that
binds to a protein involved
in the formation and
function of osteoclasts.
Denosumab is given as a
subcutaneous injection
every 6 months.
______ encompasses anesthesia
analgesia, amnesia,
relaxation, and reflex
activity. It abolishes pain
perception by interrupting
the nerve impulses to the
brain. The loss of sensation
may be partial or complete,
sometimes with the loss of
consciousness.